Evaluation of the leucocyte contamination of plateletpheresis concentrates collected on Trima separators: a review of three years of use at fixed sites and mobile units.
The Trima separator, manufactured by the Gambro, was introduced at the end of 1997 and the first separators were tested in France in early 1998. They are now routinely used on our Grenoble site for the collection of platelets and plasma. The aim of this paper is to evaluate the residual contamination of leucocytes of platelet products routinely collected on the Trima separator in a French blood transfusion center (ETS). Two separators are used at the fixed site and two separators are used for mobile collection (500 km/week). After a preliminary period of validation on site, 3237 plateletpheresis concentrates were collected by four separators qualified for fixed site or mobile unit use. An analysis taking into account the separator site (fixed or mobile) fails to reveal any significant difference for means or non-conformity percentages (data available).
Drillat
P
P
EFS Rhĵne Alpes, Site de Grenoble, La Tronche, France. phillipe.drillat@efs.sante.fr
Corne
C
C
Martre
C
C
D004867:Equipment Design; D006801:Humans; D007958:Leukocyte Count / Q000295:instrumentation; D008212:Lymphocyte Depletion / Q000295:instrumentation*; D010983:Plateletpheresis / Q000295:instrumentation*